Buccal Cytology Brush

AI-enabled Tissue Analysis for Non-Invasive Oral Brush Biopsy

OralCDx enables the painless examination of any white or red spot in the mouth to eliminate the possibility of the presence of precancerous cells.

In order to halt the progression of oral cancer, the cells can typically be removed if dysplasia is identified.

Oral cancer is increasing in low-risk populations.

Oral cancer is responsible for the deaths of approximately the same number of Americans as melanoma and twice as many as cervical cancer.
Oral cancer is on the rise among women, young people, and nonsmokers.

No known risk factors are present in at least 25% of oral cancer victims.

It is too late to detect oral cancer.
A lesion is generally dangerous, and it is frequently life-threatening, by the time it appears suspicious for cancer.
Simple to execute

No need to reschedule the patient for an in-office procedure

The procedure is painless and is well-received by patients.
Transepithelial SamplingThe collection of cells from the entire thickness of the oral epithelium is facilitated by a sampling brush that is uniquely designed.In order to identify potential abnormalities in the dense tissue of the disaggregated specimen, a proprietary imaging and neural network algorithm is necessary.

The brush biopsy is painless, causes minimal to no bleeding, and does not necessitate anesthesia.

Dependable – In the diagnosis of precancer or cancer, it has been clinically demonstrated to be at least as sensitive as a scalpel.Advanced Artificial Intelligence-Enabled

Analysis of Tissue

An advanced neural network conducts tests on each cell to identify concealed abnormalities.

The proprietary technology has been modified to ensure the most accurate detection of cellular abnormalities that are distinctive to oral brush biopsy samples.

The system identifies the most suspicious cells and cell clusters and highlights them for evaluation and diagnosis by pathologists who have received specialized training.